Jazz Pharmaceuticals plc
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $128.4M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $36.6M |
| SG&A Expense | $58.7M |
| Operating Income | $15.9M |
| Operating Margin | 12.4% |
| Interest Expense | $22.8M |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-6.8M |
| Net Margin | -5.3% |
| EPS (Basic) | $-0.23 |
| EPS (Diluted) | $-0.23 |
| Shares Outstanding (Basic) | 30.0M |
| Shares Outstanding (Diluted) | 30.0M |
| Dividends Per Share | — |